Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Vehicle-Controlled Phase I/II Clinical Study of HSK44459 Cream in Healthy Subjects and Patients With Plaque Psoriasis

NCT07623486 is registered in ClinicalTrials.gov with Haisco Pharmaceutical Group Co., Ltd. as lead sponsor.

NCT NCT07623486
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07623486 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Vehicle-Controlled Phase I/II Clinical Study of HSK44459 Cream in Healthy Subjects and Patients With Plaque Psoriasis
Lead sponsor
Haisco Pharmaceutical Group Co., Ltd.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
May 22, 2026
Completion date
June 30, 2027
Enrollment
180 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psoriasis